APA (7th ed.) Citation

Johnson, N. A., Slack, G. W., Savage, K. J., Connors, J. M., Ben-Neriah, S., Rogic, S., . . . Gascoyne, R. D. (2012). Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. Journal of clinical oncology, 30(28), 3452. https://doi.org/10.1200/JCO.2011.41.0985

Chicago Style (17th ed.) Citation

Johnson, Nathalie A., et al. "Concurrent Expression of MYC and BCL2 in Diffuse Large B-cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone." Journal of Clinical Oncology 30, no. 28 (2012): 3452. https://doi.org/10.1200/JCO.2011.41.0985.

MLA (9th ed.) Citation

Johnson, Nathalie A., et al. "Concurrent Expression of MYC and BCL2 in Diffuse Large B-cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone." Journal of Clinical Oncology, vol. 30, no. 28, 2012, p. 3452, https://doi.org/10.1200/JCO.2011.41.0985.